VentriPoint Diagnostics Ltd.
VPTDF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 93.5% | -27.8% | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | -$0 |
| % Margin | 100% | 86.3% | 84.8% | – |
| R&D Expenses | $1 | $1 | $1 | $0 |
| G&A Expenses | $3 | $3 | $3 | $3 |
| SG&A Expenses | $4 | $4 | $4 | $3 |
| Sales & Mktg Exp. | $1 | $1 | $1 | $1 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $5 | $5 | $5 | $4 |
| Operating Income | -$5 | -$5 | -$5 | -$4 |
| % Margin | -5,045.4% | -10,024.8% | -7,204% | – |
| Other Income/Exp. Net | -$0 | $0 | $0 | -$0 |
| Pre-Tax Income | -$5 | -$5 | -$5 | -$4 |
| Tax Expense | -$0 | $0 | $0 | $0 |
| Net Income | -$5 | -$5 | -$5 | -$4 |
| % Margin | -5,169.1% | -9,905.7% | -7,148.3% | – |
| EPS | -0.031 | -0.031 | -0.031 | -0.029 |
| % Growth | 0% | 0.3% | -9.5% | – |
| EPS Diluted | -0.031 | -0.031 | -0.031 | -0.029 |
| Weighted Avg Shares Out | 157 | 157 | 156 | 136 |
| Weighted Avg Shares Out Dil | 157 | 157 | 156 | 136 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$5 | -$5 | -$5 | -$4 |
| % Margin | -5,002% | -9,651.4% | -7,032.3% | – |